Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children
- Conditions
- Community Acquired Pneumonia
- First Posted Date
- 2019-11-08
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 9207
- Registration Number
- NCT04158310
Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients
Phase 2
- Conditions
- Functional Dyspepsia
- Interventions
- Drug: Aolanti Weipang TabletsDrug: Placebo
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 236
- Registration Number
- NCT03971383
- Locations
- 🇨🇳
The Second People's Hospital of Fujian Province, Fuzhou, Fujian, China
Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms
Not Applicable
- Conditions
- Severe Influenza
- Interventions
- First Posted Date
- 2019-05-13
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT03947411
- Locations
- 🇨🇳
The First Affliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2019-08-01
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT03641794
- Locations
- 🇨🇳
PKUCare Luzhong Hospital, Zibo, Shandong, China
Study of Aolanti Weikang Tablets in Healthy Volunteers
Phase 1
Completed
- Conditions
- Functional Dyspepsia
- Interventions
- Other: Placebo
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT03358485
- Locations
- 🇨🇳
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, China
Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis
Phase 4
- Conditions
- Acute Tonsillitis
- Interventions
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT03134443
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis
Phase 4
- Conditions
- Acute Exacerbation of Chronic Bronchitis
- Interventions
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT03132610
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis
Phase 4
- Conditions
- Acute Bronchitis
- Interventions
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT03132623
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
A Study of SC10914 in Patients With Advanced Solid Tumors
- First Posted Date
- 2016-10-20
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT02940132
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.
Phase 4
- Conditions
- Bronchitis
- Interventions
- Drug: Standard treatment+Xiyanping injectionDrug: Standard treatment only
- First Posted Date
- 2016-10-19
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT02937857
- Locations
- 🇨🇳
Guangzhou women and children health care center, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath